Differential sequential patterns supporting insulin therapy of new-onset type 1 diabetes

被引:10
作者
Deja, Rafal [1 ]
Froelich, Wojciech [2 ]
Deja, Grazyna [3 ]
机构
[1] Acad Business Dabrowa Gornicza, Dept Comp Sci, Dabrowa Gornicza, Poland
[2] Univ Silesia, Inst Comp Sci, Sosnowiec, Poland
[3] Sch Med Katowice, Dept Pediat Pediat Endocrinol & Diabet, Katowice, Poland
来源
BIOMEDICAL ENGINEERING ONLINE | 2015年 / 14卷
关键词
Data mining; Medical patterns; Diabetes mellitus; CHILDREN;
D O I
10.1186/s12938-015-0004-x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background: In spite of numerous research efforts on supporting the therapy of diabetes mellitus, the subject still involves challenges and creates active interest among researchers. In this paper, a decision support tool is presented for setting insulin therapy in new-onset type 1 diabetes. Methods: The concept of differential sequential patterns (DSPs) is introduced with the aim of representing deviations in the patient's blood glucose level (BGL) and the amount of insulin injections administered. The decision support tool is created using data mining algorithms for discovering sequential patterns. Results: By using the DSPs, it is possible to support the physician's decisionmaking concerning changing the treatment (i.e., whether to increase or decrease the insulin dosage). The other contributions of the paper are an algorithm for generating DSPs and a new method for evaluating nocturnal glycaemia. The proposed qualitative evaluation of nocturnal glycaemia improves the generalization capabilities of the DSPs. Conclusions: The usefulness of the proposed approach was evident in the results of experiments in which juvenile diabetic patients actual data were used. It was confirmed that the proposed DSPs can be used to guide the therapy of numerous juvenile patients with type 1 diabetes.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] New-Onset Diabetes After COVID-19
    Kim, Sun H.
    Arora, Ipsa
    Hsia, Daniel S.
    Knowler, William C.
    LeBlanc, Erin
    Mylonakis, Eleftherios
    Pratley, Richard
    Pittas, Anastassios G.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (11) : E1164 - E1174
  • [22] Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
    Ali, Mohammad Alhadj
    Liu, Yuk-Fun
    Arif, Sefina
    Tatovic, Danijela
    Shariff, Hina
    Gibson, Vivienne B.
    Yusuf, Norkhairin
    Baptista, Roman
    Eichmann, Martin
    Petrov, Nedyalko
    Heck, Susanne
    Yang, Jennie H. M.
    Tree, Timothy I. M.
    Pujol-Autonell, Irma
    Yeo, Lorraine
    Baumard, Lucas R.
    Stenson, Rachel
    Howell, Alex
    Clark, Alison
    Boult, Zoe
    Powrie, Jake
    Adams, Laura
    Wong, Florence S.
    Luzio, Stephen
    Dunseath, Gareth
    Green, Kate
    O'Keefe, Alison
    Bayly, Graham
    Thorogood, Natasha
    Andrews, Robert
    Leech, Nicola
    Joseph, Frank
    Nair, Sunil
    Seal, Susan
    Cheung, Hoyee
    Beam, Craig
    Hills, Robert
    Peakman, Mark
    Dayan, Colin M.
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (402)
  • [23] Unusual Presentation and Complications of New-Onset Type 1 Diabetes in a 3-Year-Old
    Van Anh, Khanh-Van Yveline
    Tieh, Peter
    Desselle, Bonnie
    CLINICAL PEDIATRICS, 2020, 59 (01) : 101 - 103
  • [24] Success with lifestyle monotherapy in youth with new-onset type 2 diabetes
    Wittmeier, Kristy D. M.
    Wicklow, Brandy A.
    Sellers, Elizabeth A. C.
    Griffith, Angella T. R.
    Dean, Heather J.
    McGavock, Jonathan M.
    PAEDIATRICS & CHILD HEALTH, 2012, 17 (03) : 129 - 132
  • [25] Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
    Rigby, Mark R.
    Harris, Kristina M.
    Pinckney, Ashley
    DiMeglio, Linda A.
    Rendell, Marc S.
    Felner, Eric I.
    Dostou, Jean M.
    Gitelman, Stephen E.
    Griffin, Kurt J.
    Tsalikian, Eva
    Gottlieb, Peter A.
    Greenbaum, Carla J.
    Sherry, Nicole A.
    Moore, Wayne V.
    Monzavi, Roshanak
    Willi, Steven M.
    Raskin, Philip
    Keyes-Elstein, Lynette
    Long, S. Alice
    Kanaparthi, Sai
    Lim, Noha
    Phippard, Deborah
    Soppe, Carol L.
    Fitzgibbon, Margret L.
    McNamara, James
    Nepom, Gerald T.
    Ehlers, Mario R.
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (08) : 3285 - 3296
  • [26] A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes
    Marino, Katherine R.
    Lundberg, Rachel L.
    Jasrotia, Aastha
    Maranda, Louise S.
    Thompson, Michael J.
    Barton, Bruce A.
    Alonso, Laura C.
    Nwosu, Benjamin Udoka
    PLOS ONE, 2017, 12 (05):
  • [27] Can biochemical markers discriminate between new-onset type 1 and type 2 diabetes mellitus children?
    Wolfsdorf, Joseph I.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (12): : 800 - 801
  • [28] Insulin therapy for diabetes mellitus type 1
    Dreyer, M.
    DIABETOLOGE, 2014, 10 (06): : 453 - 459
  • [29] Transient Thyroid Dysfunction in New-Onset Type 1 Diabetes: Reassessing Test Timing for Accurate Results
    Ustuntas, Talha
    Atabek, Mehmet Emre
    Eklioglu, Beray Selver
    Dibeklioglu, Saime Ergen
    TURKISH ARCHIVES OF PEDIATRICS, 2025, 60 (02):
  • [30] Infantile cerebral infarction caused by severe diabetic ketoacidosis in new-onset type 1 diabetes mellitus
    Suzuki, Junichi
    Fuchigami, Tatsuo
    Kawamura, Kengo
    Aoki, Masako
    Urakami, Tatsuhiko
    Morioka, Ichiro
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2019, 32 (12) : 1391 - 1394